Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Journal Article
Daniilidis, A., & Pados G. (2018).  Comments on the ESHRE recommendations for the treatment of minimal endometriosis in infertile women.. Reprod Biomed Online. 36(1), 84-87.
Poulakos, P., Mintziori G., Tsirou E., Taousani E., Savvaki D., Harizopoulou V., et al. (2015).  Comments on gestational diabetes mellitus: from pathophysiology to clinical practice.. Hormones (Athens). 14(3), 335-44.
Bourdoumis, A., Calleary J., & Sountoulides P. (2019).  Commentary/guest editorial on: "Treatment of fragmented and severely encrusted urethral D-J stent forgotten for 11 years through multimodal endourological methods".. Urol Ann. 11(1), 113-114.
Saratzis, A., Melas N., & Saratzis N. (2010).  Commentary: popliteal approach in the supine position after failed antegrade angioplasty for chronic superficial femoral artery occlusion.. J Endovasc Ther. 17(2), 259-60.
Tsoulfas, G., & Agorastou P. (2013).  Commentary on "Prophylaxis against HBV recurrence after liver transplantation for HBV-related endstage liver diseases with severe hypersplenism and splenomegaly: Role of splenectomy".. J Surg Res. 183(2), 548-9.
Tsoulfas, G. (2011).  Commentary on "Preemptive therapy with steroids but not macrolides improves gas exchange in caustic-injured donor lungs".. J Surg Res. 171(2), e175-7.
Tsoulfas, G. (2013).  Commentary on "Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation".. J Surg Res. 185(1), e59-60.
Tsoulfas, G. (2013).  Commentary on "Liver transplantation with donation-after-cardiac-death donors: a comprehensive update".. J Surg Res. 184(2), 794-5.
Tsoulfas, G. (2013).  Commentary on: Lipid peroxidation in machine perfusion of older donor kidneys.. J Surg Res. 185(1), e43-4.
Tsoulfas, G. (2013).  Commentary on "Interaction between Kupffer cells and platelets in the early period of hepatic ischemia-reperfusion injury".. J Surg Res. 179(1), e51-2.
Tsivgoulis, G., Katsanos A. H., Voumvourakis K., Hadjigeorgiou G. M., Heliopoulos I., Karapanayiotides T., et al. (2018).  Commentary on: Comparing the efficacy of disease-modifying therapies in multiple sclerosis.. Mult Scler Relat Disord. 21, 117-119.
Tsoulfas, G. (2013).  Commentary on "Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning".. J Surg Res. 185(1), e37-8.
Tsoulfas, G. (2013).  Commentary on: Age-related differences in hepatic ischemia/reperfusion: gene activation, liver injury, and protective effect of melatonin.. J Surg Res. 185(1), e51-2.
Polyzos, S. A., Kang E. Seok, Tsochatzis E. A., Kechagias S., Ekstedt M., Xanthakos S., et al. (2020).  Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name.. Metabolism. 113, 154413.
Papaefthymiou, A., Doulberis M., Polyzos S. A., Romiopoulos I., Berdeni Α., Zavos C., et al. (2021).  Commentary: are blood and saliva sources of COVID-19 spread?. Eur Rev Med Pharmacol Sci. 25(15), 4872-4874.
Natsis, K., & Piagkou M. (2013).  Commentary.. J Neurosci Rural Pract. 4(4), 397-8.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2013).  Comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property".. Dig Liver Dis. 45(1), 82-3.
Kountouras, J., Polyzos S. A., Doulberis M., Stergiopoulos C., & Katsinelos P. (2018).  Comment on "Therapeutic Application of an Extract of Ameliorates the Development of Allergic Airway Disease".. J Immunol. 200(9), 3027.
Paschou, S. A., Sydney G. I., Ioakim K. J., Kotsa K., & Goulis D. G. (2020).  Comment on the systematic review and meta-analysis titled "Gestational diabetes and the risk of cardiovascular disease in women".. Hormones (Athens). 19(3), 447-448.
Georgakarakos, E., Ioannou C. V., Kostas T., Katsamouris A. N., & Papaharilaou Y. (2010).  Comment on "the influence of wall stress on AAA growth and biomarkers".. Eur J Vasc Endovasc Surg. 39(6), 796; author reply 797.
Kountouras, J., Tsiaousi E., Trigonis S., Polyzos S. A., Katsinelos P., Zavos C., et al. (2016).  Comment on "The correlation of Helicobacter pylori with the development of cholelithiasis and cholecystitis: the results of a prospective clinical study in Saudi Arabia".. Eur Rev Med Pharmacol Sci. 20(1), 3-4.
Meletis, G., Protonotariou E., Papadopoulou D., & Skoura L. (2016).  Comment on: The Carbapenemase Menace: Do Dual Mechanisms Code for More Resistance?. Infect Control Hosp Epidemiol. 37(11), 1392-1394.
P White, L., Barnes R. A., Gorton R., Cruciani M., & Loeffler J. (2019).  Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.. J Antimicrob Chemother. 74(2), 532-533.
Cholongitas, E., Spyrou S., Georgousaki C., & Dasenaki M. (2010).  Comment on: Recurrent skin reaction attributable to darbepoetin alfa in a patient with chronic renal failure.. Ren Fail. 32(4), 528.
Tsivgoulis, G., Palaiodimou L., Katsanos A. H., Voumvourakis K., Hadjigeorgiou G. M., Heliopoulos I., et al. (2019).  Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis".. CNS Drugs. 33(3), 293-295.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.